Top Story

Tiotropium reduced acute exacerbations among patients with COPD

September 6, 2017

Read the Perspective from Tim Scialla, MD

Tiotropium use was effective in improving lung function and quality of life and reduced the frequency of acute exacerbations compared with placebo in patients with early-stage COPD, according to findings recently published in The New England Journal of Medicine.

Patients with mild or moderate COPD rarely receive medications, because they have few symptoms,” Yumin Zhou, MD, PhD, of the National Center for Respiratory Diseases, Guangzhou, China, and colleagues wrote. “We hypothesized that long-term use of tiotropium would improve lung function and ameliorate the decline in lung function in patients with mild or moderate COPD.”

In the Journals

COPD, asthma cited as important contributors to disease burden worldwide

August 25, 2017
In 2015, chronic obstructive pulmonary disease contributed to 3.2 million deaths worldwide and asthma contributed to 0.4 million deaths. These statistics demonstrate…

Revefenacin shows promise in phase 3 trial for treating COPD

July 21, 2017
A 12-month phase 3 safety study demonstrated positive results of revefenacin for the treatment of chronic obstructive pulmonary disease, according to a press release…
Meeting News

PCOS linked to higher asthma risk

May 30, 2017
Women with polycystic ovary syndrome have an increased risk for developing asthma, according to data presented at the American Thoracic Society International…
More Headlines »
CME Article

Cystic Fibrosis and CRMS Screening: What the Primary Care Pediatrician Should Know

Pediatric Annals, December 2010, Volume 39 Issue 12
“Every physician’s first duty is to diagnose — accurately and promptly.” This mantra is taught…
More »
Meeting News

VIDEO: MedImmune collaborations produce three discoveries in COPD

October 28, 2016
More »